Compensation award — excluded from discretionary-purchase analysis.
Traded Feb 13, 2026 · Filed Feb 17, 2026
Procter & Gamble's Chf Rsch, Dev & Innov Officer sold $2.46M of Procter & Gamble shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,461,609
Shares × reported transaction price
22 days after results of Jan 22, 2026, 70 days before results of Apr 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $160.07 on Feb 13, 2026, 16% above its 52-week low and 9% below its high, after a 12% rise over the previous 30 trading days
52-week range $138.04 (Jan 7, 2026) to $176.26 (Mar 10, 2025), 58% of the way up, from 251 adjusted closes. 30 trading days earlier: $143.31 on Dec 31, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.2% | +1.0% | +3.2% |
| 30 days | -8.0% | -5.5% | -2.5% |
| 90 days | -9.9% | +6.9% | -16.8% |
| 180 days | -8.8% | +12.6% | -21.4% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
11 different filers disclosed PG within 90 days. Disclosed 38 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.